Arp Americas »

Amicus Therapeutics shares owned by Arp Americas

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Arp Americas from 13F filings

Historical chart of Arp Americas investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Arp Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Arp Americas

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 871k 14.24

More positions owned by Arp Americas

Comerica Incorporated (CMA)
Janus Henderson Group Ord Shs (JHG)
Cidara Therapeutics Com New (CDTX)
Norfolk Southern (NSC)
Electronic Arts (EA)
Ceridian Hcm Hldg (DAY)
Amicus Therapeutics (FOLD)
EXACT Sciences Corporation (EXAS)
Avidity Biosciences Ord (RNA)
Confluent Class A Com (CFLT)
Cadence Bank (CADE)
Warner Bros Discovery Com Ser A (WBD)
Alexander & Baldwin (ALEX)
Dynavax Technologies Corp Com New (DVAX)
Heritage Commerce (HTBK)

View all positions for Arp Americas

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Perceptive Advisors
UBS Group
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics